Â鶹AV

Home

Nader Sadeghi

Academic title(s): 

Professor and Chair, Department of Otolaryngology - Head and Neck Surgery Â鶹AV,
Professor, Department of Oncology, Â鶹AV
Director of Â鶹AV Head and Neck Cancer Program.

Nader Sadeghi
Degree(s): 

MD, FRCSC

Location: 
Â鶹AV Health Centre (MUHC - Glen) Hospital
Hospital title: 
Chief of Otolaryngology - Head and Neck Surgery MUHC
Senior Researcher, Research Institute of MUHC
Current research: 

Principal investigator, Neoadjuvant Chemotherapy and Transoral Robotic Surgery for oropharyngeal cancer (NECTORS trial), Robotic surgery in head and neck cancer, cancer biology, human papilloma virus (HPV) and head and neck cancer, liquid biopsy, quality of life and outcomes in head and neck cancer, clinical trials, tumor immune micro-environment

Clinical Interests: 
  • Transoral Robotic Surgery
  • Transoral Laser Microsurgery
  • Head and Neck Oncology
  • Salivary gland surgery
  • Head and Neck Endocrine Surgery
Language(s) spoken: 
French
English
Biography: 

Dr. Sadeghi is a graduate of Â鶹AV Medicine and residency in Otolaryngology-Head and Neck Surgery. He then completed a fellowship training in Head and Neck Oncology Surgery at Rush-Presbyterian-St. Luke's Medical Center in Chicago. Following his early career at Â鶹AV, he moved to George Washington University in Washington, DC, where he served as Professor of Surgery and Director of Head and Neck Surgery. In 2017, he returned to Â鶹AV to lead the department and Â鶹AV's head and neck cancer care program.
Dr. Sadeghi has an international reputation for his pioneering work in adaptive and personalized approach to oropharyngeal cancer with Transoral Robotic Surgery, defining a new paradigm for oropharyngeal cancer care with neoadjuvant systemic treatment and transoral robotic surgery (NECTORS). He has pioneered the NECTORS approach with early feasibility studies followed by phase II clinical trials, introducing a paradigm change to the field. He lectures internationally on the topic and continues to investigate the field of oropharyngeal cancer with studies of immune enhancement and targeted approaches before surgery to allow less invasive yet more effective surgical care, improving outcomes in cancer cure and, equally important, patients-reported outcomes in quality of life and function after cancer care.

Selected publications: 

National Center for Biotechnology Information 
Back to top